Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,018 | -18,517 | -11,797 | -5,809 | -41,009 |
| Depreciation Amortization | 1,777 | 1,315 | 1,086 | 602 | 2,333 |
| Accounts receivable | 1,047 | N/A | N/A | N/A | -966 |
| Accounts payable and accrued liabilities | -2,769 | N/A | N/A | N/A | 181 |
| Other Working Capital | -2,693 | -4,984 | -2,657 | -1,364 | -1,662 |
| Other Operating Activity | 15,099 | 10,387 | 6,233 | 3,853 | 40,202 |
| Operating Cash Flow | $-11,557 | $-11,799 | $-7,135 | $-2,718 | $-921 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -803 | -553 | -425 | -274 | -1,101 |
| Net Acquisitions | 28,160 | 28,160 | 28,426 | N/A | N/A |
| Purchase Of Investment | -700 | -700 | -700 | -700 | N/A |
| Purchase Sale Intangibles | -1,901 | -1,260 | -768 | -355 | -4,876 |
| Other Investing Activity | -1,901 | -1,260 | -768 | -355 | -4,876 |
| Investing Cash Flow | $24,756 | $25,647 | $26,533 | $-1,329 | $-5,977 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 5,000 | 5,000 | 4,853 | 100,015 |
| Debt Repayment | -10,050 | -10,050 | -10,050 | N/A | -34,500 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 25,399 |
| Other Financing Activity | -10,992 | -9,229 | -6,798 | -3,245 | -103,236 |
| Financing Cash Flow | $-16,042 | $-14,279 | $-11,848 | $1,608 | $-12,322 |
| Exchange Rate Effect | -44 | 114 | 100 | 14 | -112 |
| Beginning Cash Position | 6,578 | 6,578 | 6,578 | 6,578 | 25,910 |
| End Cash Position | 3,691 | 6,261 | 14,228 | 4,153 | 6,578 |
| Net Cash Flow | $-2,887 | $-317 | $7,650 | $-2,425 | $-19,332 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,557 | -11,799 | -7,135 | -2,718 | -921 |
| Capital Expenditure | -803 | -553 | -425 | -274 | -1,101 |
| Free Cash Flow | -12,360 | -12,352 | -7,560 | -2,992 | -2,022 |